Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007 (2007), Article ID 93431, 7 pages
http://dx.doi.org/10.1155/2007/93431
Research Article

Progesterone Prevents Traumatic Brain Injury-Induced Intestinal Nuclear Factor kappa B Activation and Proinflammatory Cytokines Expression in Male Rats

Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, Jiangsu Province, China

Received 29 April 2007; Accepted 2 July 2007

Copyright © 2007 Gang Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. W. Grotz, E. A. Deitch, J. Ding, D. Xu, Q. Huang, and G. Regel, “Intestinal cytokine response after gut ischemia: role of gut barrier failure,” Annals of Surgery, vol. 229, no. 4, pp. 478–486, 1999. View at Publisher · View at Google Scholar
  2. P. L. Faries, R. J. Simon, A. T. Martella, M. J. Lee, and G. W. Machiedo, “Intestinal permeability correlates with severity of injury in trauma patients,” The Journal of Trauma, vol. 44, no. 6, pp. 1031–1036, 1998. View at Publisher · View at Google Scholar
  3. G. M. Swank and E. A. Deitch, “Role of the gut in multiple organ failure: bacterial translocation and permeability changes,” World Journal of Surgery, vol. 20, no. 4, pp. 411–417, 1996. View at Publisher · View at Google Scholar
  4. C.-H. Hang, J.-X. Shi, J.-S. Li, W. Wu, and H.-X. Yin, “Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats,” World Journal of Gastroenterology, vol. 9, no. 12, pp. 2776–2781, 2003.
  5. C.-H. Hang, J.-X. Shi, J.-S. Li, W.-Q. Li, and W. Wu, “Expressions of intestinal NF-κB, TNF-α, and IL-6 following traumatic brain injury in rats,” Journal of Surgical Research, vol. 123, no. 2, pp. 188–193, 2005. View at Publisher · View at Google Scholar · View at PubMed
  6. F. Chen, V. Castranova, and X. Shi, “New insights into the role of nuclear factor-κB in cell growth regulation,” American Journal of Pathology, vol. 159, no. 2, pp. 387–397, 2001.
  7. M. Castro-Caldas, A. F. Mendes, A. P. Carvalho, C. B. Duarte, and M. C. Lopes, “Dexamethasone prevents interleukin-1β-induced nuclear factor-κB activation by upregulating IκB-α synthesis, in lymphoblastic cells,” Mediators of inflammation, vol. 12, no. 1, pp. 37–46, 2003. View at Publisher · View at Google Scholar · View at PubMed
  8. F. R. Homaidan, I. Chakroun, and M. E. El-Sabban, “Regulation of nuclear factor-κB in intestinal epithelial cells in a cell model of inflammation,” Mediators of Inflammation, vol. 12, no. 5, pp. 277–283, 2003. View at Publisher · View at Google Scholar · View at PubMed
  9. E. C. Claud, X. Zhang, E. O. Petrof, and J. Sun, “Developmentally regulated tumor necrosis factor-α induced nuclear factor κB activation in intestinal epithelium,” American Journal of Physiology, vol. 292, no. 5, pp. G1411–G1419, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. P. A. Baeuerle and D. Baltimore, “Nf-κB: ten years after,” Cell, vol. 87, no. 1, pp. 13–20, 1996. View at Publisher · View at Google Scholar
  11. J. W. Lee, M. S. Lee, and T. H. Kim et al., “Inhibitory effect of inflexinol on nitric oxide generation and iNOS expression via inhibition of NF-κB activation,” Mediators of Inflammation, vol. 2007, Article ID 93148, 9 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. C. Fiocchi, “Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions,” American Journal of Physiology, vol. 273, no. 4, part 1, pp. G769–G775, 1997.
  13. T. A. Pritts, M. R. Moon, J. E. Fischer, A. L. Salzman, and P.-O. Hasselgren, “Nuclear factor-κB is activated in intestinal mucosa during endotoxemia,” Archives of Surgery, vol. 133, no. 12, pp. 1311–1315, 1998. View at Publisher · View at Google Scholar
  14. M. F. Neurath, S. Pettersson, K.-H. Meyer zum Buschenfelde, and W. Strober, “Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice,” Nature Medicine, vol. 2, no. 9, pp. 998–1004, 1996. View at Publisher · View at Google Scholar
  15. D. G. Stein, “Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?,” Trends in Neurosciences, vol. 24, no. 7, pp. 386–391, 2001. View at Publisher · View at Google Scholar
  16. D. W. Wright, A. L. Kellermann, and V. S. Hertzberg et al., “ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury,” Annals of Emergency Medicine, vol. 49, no. 4, pp. 391–402, 2007. View at Publisher · View at Google Scholar · View at PubMed
  17. J. He, C.-O. Evans, S. W. Hoffman, N. M. Oyesiku, and D. G. Stein, “Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury,” Experimental Neurology, vol. 189, no. 2, pp. 404–412, 2004. View at Publisher · View at Google Scholar · View at PubMed
  18. E. H. Pettus, D. W. Wright, D. G. Stein, and S. W. Hoffman, “Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury,” Brain Research, vol. 1049, no. 1, pp. 112–119, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. D. M. Feeney, M. G. Boyeson, R. T. Linn, H. M. Murraya, and W. G. Daila, “Responses to cortical injury—I: methodology and local effects of contusions in the rat,” Brain Research, vol. 211, no. 1, pp. 67–77, 1981. View at Publisher · View at Google Scholar
  20. M. Djebaili, S. W. Hoffman, and D. G. Stein, “Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex,” Neuroscience, vol. 123, no. 2, pp. 349–359, 2004. View at Publisher · View at Google Scholar
  21. C. W. Goss, S. W. Hoffman, and D. G. Stein, “Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study,” Pharmacology Biochemistry and Behavior, vol. 76, no. 2, pp. 231–242, 2003. View at Publisher · View at Google Scholar
  22. K. De Bosscher, M. L. Schmitz, W. V. Berghe, S. Plaisance, W. Fiers, and G. Haegeman, “Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 25, pp. 13504–13509, 1997. View at Publisher · View at Google Scholar
  23. E. Kalkhoven, S. Wissink, P. T. van der Saag, and B. van der Burg, “Negative interaction between the RelA(p65) subunit of NF-κB and the progesterone receptor,” The Journal of Biological Chemistry, vol. 271, no. 11, pp. 6217–6224, 1996. View at Publisher · View at Google Scholar
  24. V. C. Allport, D. M. Slater, R. Newton, and P. R. Bennett, “NF-κB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH),” Molecular Human Reproduction, vol. 6, no. 6, pp. 561–565, 2000. View at Publisher · View at Google Scholar
  25. V. C. Allport, D. Pieber, D. M. Slater, R. Newton, J. O. White, and P. R. Bennett, “Human labour is associated with nuclear factor-κB activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’,” Molecular Human Reproduction, vol. 7, no. 6, pp. 581–586, 2001. View at Publisher · View at Google Scholar
  26. S. Wissink, E. C. van Heerde, B. van der Burg, and P. T. van der Saag, “A dual mechanism mediates repression of NF-κB activity by glucocorticoids,” Molecular Endocrinology, vol. 12, no. 3, pp. 355–363, 1998. View at Publisher · View at Google Scholar
  27. S. Horie, T. Harada, M. Mitsunari, F. Taniguchi, T. Iwabe, and N. Terakawa, “Progesterone and progestational compounds attenuate tumor necrosis factor α-induced interleukin-8 production via nuclear factor κB inactivation in endometriotic stromal cells,” Fertility and Sterility, vol. 83, no. 5, pp. 1530–1535, 2005. View at Publisher · View at Google Scholar · View at PubMed
  28. S. Davies, D. Dai, I. Feldman, G. Pickett, and K. K. Leslie, “Identification of a novel mechanism of NF-κB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2,” Gynecologic Oncology, vol. 94, no. 2, pp. 463–470, 2004. View at Publisher · View at Google Scholar · View at PubMed
  29. R. Sercombe, Y. R. Tran Dinh, and P. Gomis, “Cerebrovascular inflammation following subarachnoid hemorrhage,” The Japanese Journal of Pharmacology, vol. 88, no. 3, pp. 227–249, 2002. View at Publisher · View at Google Scholar
  30. J. L. Gotkin, J. Celver, and P. McNutt et al., “Progesterone reduces lipopolysaccharide induced interleukin-6 secretion in fetoplacental chorionic arteries, fractionated cord blood, and maternal mononuclear cells,” American Journal of Obstetrics and Gynecology, vol. 195, no. 4, pp. 1015–1019, 2006. View at Publisher · View at Google Scholar · View at PubMed
  31. A. D. Shields, J. Wright, and D. J. Paonessa et al., “Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model,” American Journal of Obstetrics and Gynecology, vol. 193, no. 3, supplement 1, pp. 1144–1148, 2005. View at Publisher · View at Google Scholar · View at PubMed
  32. O. Kurachi, H. Matsuo, T. Samoto, and T. Maruo, “Tumor necrosis factor-α expression in human uterine leiomyoma and its down-regulation by progesterone,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 5, pp. 2275–2280, 2001. View at Publisher · View at Google Scholar